Clinical trial
A prospective, phase IV, open-label, multi-center study evaluating changes in bone marrow morphology in adult subjects receiving romiplostim for the treatment of thrombocytopenia associated with immune (idiopathic) thrombocytopenia purpura (ITP)
The primary objective of this study is to evaluate the incidence of collagen fibrosis as evidenced by trichrome staining at Year 1, Year 2, or Year 3 after initial exposure of romiplostim.
| Category | Value |
|---|---|
| Study start date | 2009-05-19 |